MedTrace Logo

Prevention of Gestational Diabetes Mellitus With Lifestyle Intervention Among Women of Advanced Maternal Age.

NCT05421845 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 346

Last updated 2022-06-16

No results posted yet for this study

Summary

This is a single-blind randomized controlled trial, aiming to evaluate the preventive effects of mobile-based combining with hospital-based lifestyle interventions on GDM among women with advanced maternal age. It will be conducted in Beijing, with a sample size of 346. All eligible pregnant women will be randomly assigned to either the intervention or control group, and followed up to delivery.

Conditions

  • Gestational Diabetes Mellitus

Interventions

BEHAVIORAL

mobile-based combining with hospital-based lifestyle interventions

The same as that stated in arm descriptions.

Sponsors & Collaborators

  • Peking University First Hospital

    collaborator OTHER

  • Peking University

    lead OTHER

Principal Investigators

  • Yumei Wei, PhD · Peking University First Hospital

  • Yubo Zhou · Peking University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-31
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05421845 on ClinicalTrials.gov